Matches in Wikidata for { <http://www.wikidata.org/entity/Q96682984> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q96682984 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96682984 description "scientific article published on 24 June 2020" @default.
- Q96682984 description "wetenschappelijk artikel" @default.
- Q96682984 description "наукова стаття, опублікована 24 червня 2020" @default.
- Q96682984 name "Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer" @default.
- Q96682984 name "Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer" @default.
- Q96682984 type Item @default.
- Q96682984 label "Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer" @default.
- Q96682984 label "Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer" @default.
- Q96682984 prefLabel "Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer" @default.
- Q96682984 prefLabel "Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer" @default.
- Q96682984 P1433 Q96682984-1F7CD461-2C44-481A-A9D5-7502FB015F65 @default.
- Q96682984 P1476 Q96682984-F94335E5-CA58-4692-9BD4-C14372DE2E45 @default.
- Q96682984 P2093 Q96682984-037AEA43-14F1-4C1E-8C0D-698125EF858F @default.
- Q96682984 P2093 Q96682984-124AD343-A708-49DE-A241-AFD33C7F7CA1 @default.
- Q96682984 P2093 Q96682984-18E0D29F-B817-4FC4-AFA0-8E8313833CB3 @default.
- Q96682984 P2093 Q96682984-298BFFC6-85AA-4300-B604-21E9468200A6 @default.
- Q96682984 P2093 Q96682984-40B1E375-AD7A-4DCA-B87C-2E2BF6B35D1C @default.
- Q96682984 P2093 Q96682984-D860434C-9BA2-4140-9EC1-1DD80C932388 @default.
- Q96682984 P31 Q96682984-3BB50A35-D8F9-425C-8939-6F367DDC3FEB @default.
- Q96682984 P356 Q96682984-EBD4B95F-A1F8-4BFD-8E68-CD1D25B2B053 @default.
- Q96682984 P50 Q96682984-803A3F91-E646-4C99-87F7-5C6210D95FB3 @default.
- Q96682984 P577 Q96682984-5B47F1B5-7F75-4573-9797-A99023E6AD65 @default.
- Q96682984 P698 Q96682984-7F225690-2186-4CC8-AB20-027BE5CC9D81 @default.
- Q96682984 P921 Q96682984-BE8AA399-4117-46C0-9667-66AF1AC5E729 @default.
- Q96682984 P356 DMD.119.090092 @default.
- Q96682984 P698 32581049 @default.
- Q96682984 P1433 Q1261140 @default.
- Q96682984 P1476 "Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer" @default.
- Q96682984 P2093 "Jane Royalty" @default.
- Q96682984 P2093 "Jessica Rehmel" @default.
- Q96682984 P2093 "Palaniappan Kulanthaivel" @default.
- Q96682984 P2093 "Sonya C Chapman" @default.
- Q96682984 P2093 "Stephen D Hall" @default.
- Q96682984 P2093 "Yingying Guo" @default.
- Q96682984 P31 Q13442814 @default.
- Q96682984 P356 "10.1124/DMD.119.090092" @default.
- Q96682984 P50 Q94547630 @default.
- Q96682984 P577 "2020-06-24T00:00:00Z" @default.
- Q96682984 P698 "32581049" @default.
- Q96682984 P921 Q323936 @default.